Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00602563 · ClinicalTrials.gov registry record · NA
Attention Training for Generalized Anxiety Disorder
A NA study, sponsored by San Diego State University.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
NCT00602563 is a NA study that has completed, run by San Diego State University. The registered enrollment target is 193 participants.
The verdict
NCT00602563, a NA study, has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
Study Summary
Generalized Anxiety Disorder (GAD) has high prelevance (up to 8.5%; Roy-Byrne \& Wagner, 2004) and leads to functional impairment (Wittchen et al., 2002; Ballenger et al., 2001). Researchers have demonstrated a relationship between attention bias to threatening information and GAD. However, this knowledge has not yet been translated into effective treatments. The goal of this project is develop and test a new computerized treatment for Generalized Anxiety Disorder.
Interventions
- BEHAVIORAL AMP
- BEHAVIORAL Applied Relaxation (AR)
- BEHAVIORAL Clinical Monitoring (CM)
- BEHAVIORAL Combining the AMP and AR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2007-12 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00602563
The ClinicalTrials.gov registry entry for NCT00602563 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is San Diego State University, which has 118 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which AMP is the first listed.
NCT00602563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00602563 about?
NCT00602563 is a clinical study titled "Attention Training for Generalized Anxiety Disorder". Generalized Anxiety Disorder (GAD) has high prelevance (up to 8.5%; Roy-Byrne \& Wagner, 2004) and leads to functional impairment (Wittchen et al., 2002; Ballenger et al., 2001). Researchers have demonstrated a relationship between attention bias to threatening information and GAD. However, this kno...
What is the current status of trial NCT00602563?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2007-12. Estimated completion is 2016-06.
What interventions are being tested in trial NCT00602563?
The interventions under investigation include: AMP (BEHAVIORAL), Applied Relaxation (AR) (BEHAVIORAL), Clinical Monitoring (CM) (BEHAVIORAL), Combining the AMP and AR (BEHAVIORAL).
Who is sponsoring clinical trial NCT00602563?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.